Adefovir dipivoxil (ADV) demonstrates anti-viral efficacy and clinical benefit in the treatment of lamivudine resistant (LAM-R) chronic HBV: An analysis of four clinical trials. - Peters,M.; Schiff,E.; Benhamou,Y. (Gastroenterology, 2002)